Accustem Sciences Inc.
ACUT
Rank in Stocks
#31951
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Share Price
$0.13687
Last synced: 2026-11-11
Market Cap
$2.20M
Change (1 day)
5.28%
Change (1 year)
-84.08%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Accustem Sciences Inc. (ACUT)
Category
Healthcare
EPS for Accustem Sciences Inc. (ACUT)
EPS as of June 2026 TTM: $-0.11
According to Accustem Sciences Inc.'s latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2025 the company had an EPS of $-0.12, an increase over its 2024 EPS of $-0.13.
EPS history for Accustem Sciences Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.11 | -8.33% |
| 2025 | $-0.12 | -7.69% |
| 2024 | $-0.13 | -27.78% |
| 2023 | $-0.18 | -47.06% |
| 2022 | $-0.34 | 474.32% |
| 2021 | $-0.06 | 1,133.33% |
| 2020 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 709.09% |
US
|
|
| $15.66 | -14,336.36% |
US
|
|
| $-7.07 | 6,327.27% |
US
|
|
| $-5.29 | 4,709.09% |
AU
|
|
| $12.73 | -11,674.73% |
BE
|
Questions about Accustem Sciences Inc.'s earnings per share (EPS)
What is Accustem Sciences Inc.'s earnings per share (EPS)?
Accustem Sciences Inc.'s earnings per share (EPS) over the last twelve months is $-0.11, as of Jun 2026.
What was Accustem Sciences Inc.'s earnings per share (EPS) in 2025?
In 2025, Accustem Sciences Inc.'s earnings per share (EPS) was $-0.12, compared with $-0.13 in 2024.
How has Accustem Sciences Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Accustem Sciences Inc.'s earnings per share (EPS) was highest in 2020 (0.00) and lowest in 2022 ($-0.34).
How does Accustem Sciences Inc.'s earnings per share (EPS) compare with similar companies?
Accustem Sciences Inc.'s earnings per share (EPS) ($-0.11) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.